Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS)
Recruiting · NCT06703489 · Registry updated 2026-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Safety and Performance Assessment of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere-9 VT EFS) | Arrhythmias, Cardiac, Cardiac Conduction System Disease, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tachycardia, cardiovascular disorder, heart disorder, myocardial ischemia, vascular disorder, ventricular tachycardia | Recruiting | Not applicable | 2026-09-03 | NCT06703489 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Medtronic Cardiac Ablation Solutions | 15 |
6 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beth Israel Deaconess Medical Center | Boston | United States | 462 |
| Cleveland Clinic Foundation | Cleveland | United States | 370 |
| Hospital of the University of Pennsylvania | Philadelphia | United States | 142 |
| Icahn School of Medicine at Mount Sinai | New York | United States | 342 |
| Texas Cardiac Arrhythmia Research Foundation | Austin | United States | 19 |
| Vanderbilt University Medical Center | Nashville | United States | 427 |